Am J Transplant, Volume 22, Suppl 3 Archives - Page 72 of 190 - ATC Abstracts

2022 American Transplant Congress
Inferior Kidney Transplant Outcomes in Young Adults Transplanted as Children
K. Deville, F. Rosenblum, D. R. Kelly, M. Seifert
UAB School of Medicine, Birmingham, AL
*Purpose: Adolescence (age 13-17 years) has been identified as a high-risk age interval for pediatric kidney transplant recipients, with accelerated rates of late acute rejection…
2022 American Transplant Congress
Circulating Galectin-3 Levels Increase in Syngeneic Rat Recipients of Vascularized Composite Allografts Subjected to Prolonged Ischemia
Z. Wang¹, B. Li¹, Y. Wang¹, D. Yoeli¹, N. Nakra¹, N. Limon De La Rosa¹, A. A. Su¹, A. Jani¹, D. W. Mathes¹, K. M. Washington¹, E. Farkash², C. A. Huang¹
¹University of Colorado, Denver | Anschutz Medical Campus, Aurora, CO, ²University of Michigan, Ann Arbor, Ann Arbor, MI
*Purpose: During the process of transplantation, organs and tissue are necessarily subjected to some degree of hypoxic and ischemic injury during procurement, preservation and following…
2022 American Transplant Congress
Long Term Analysis of Pediatric En-Bloc Kidney Transplantation: A Single Center Experience
H. H. Patel¹, P. Di Cocco², J. Almario², A. Fratti², S. Akshelyan², E. Benedetti², I. Tzvetanov², M. Spaggiari²
¹University of Missouri-Kansas City School of Medicine, Kansas City, MO, ²University of Illinois at Chicago, Chicago, IL
*Purpose: Pediatric en-bloc kidney transplantations for adult recipients are uncommonly performed due to unique donor characteristics, the technical challenge of the operation, and potential surgical…
2022 American Transplant Congress
Biopsy Characteristics of Kidneys from a Single Large OPO
S. Bunnapradist¹, T. Seto², A. Cohen², T. Rosenthal¹, G. Danovitch¹
¹David Geffen School of Medicine, Los Angeles, CA, ²One Legacy, Los Angeles, CA
*Purpose: As deceased donor pool have expanded, kidney biopsy has been increasingly used to help determine organ suitability for transplant. There are concerns that biopsy…
2022 American Transplant Congress
Pericardial Effusion: A Potential Late Complication of COVID-19 Infection
O. Sogbein, A. Rizvi, M. Mujtaba, S. Hussain
Internal Medicine, Division of Nephrology, University of Texas Medical Branch, Galveston, TX
*Purpose: COVID-19 infection involves entry of SARS-CoV-2 virus into cells via interaction between its spike protein and angiotensin converting enzyme resulting in an NF-κβ mediated…
2022 American Transplant Congress
Serological Response To Three, Four And Five Doses Of Sars-cov-2 Vaccine In Kidney Transplant Recipients
S. Ronicke¹, B. Osmanodja¹, K. Budde¹, A. Jens¹, C. Hammett¹, K. Nadine¹, J. Waiser¹, B. Zukunft¹, F. Bachmann¹, M. Choi¹, W. Ulrike¹, B. Eberspächer², J. Hofmann², F. Grunow¹, M. Mikhailov¹, L. Liefeldt¹, K. Eckardt¹, F. Halleck¹, E. Schrezenmeier¹
¹Department of Nephrology and Medical Intensive Care, Charité – Universitätsmedizin Berlin, Berlin, Germany, ²Labor Berlin - Charité Vivantes GmbH, Berlin, Germany
*Purpose: Mortality from COVID-19 among kidney transplant recipients (KTR) is unacceptably high, and their response to up to three vaccinations against SARS-CoV-2 is strongly impaired.…
2022 American Transplant Congress
Exploring the Differential Access Hypothesis: Do Black Kidney Transplant Candidates Have Less Social Network Access to Potential Living Donors Than White Candidates?
J. Daw¹, M. Roberts¹, T. Purnell²
¹Sociology & Criminology, The Pennsylvania State University, University Park, PA, ²Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: This study assesses the ‘differential access’ hypothesis that non-Hispanic Black kidney transplant candidates in the United States have access to fewer healthy, willing potential…
2022 American Transplant Congress
Safety and Efficacy of GLP-1 Agonists in Solid Organ Transplant Recipients
E. Heiman, D. Blanco, A. Webb
Pharmacy, Tampa General Hospital, Tampa, FL
*Purpose: Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have been shown to improve glycemic control, obesity, and cardiovascular disease in the general population. The safety and…
2022 American Transplant Congress
The SHELTER Trial of Transplanting Donor Hepatitis C Virus RNA+ Lungs Into Uninfected Recipients
V. Potluri¹, P. Reese¹, S. Prenner¹, H. Mentch¹, D. Goldberg², T. Claridge¹, J. Smith¹, C. Gentile¹, V. Van Deerlin¹, R. Reddy¹, T. Fallah¹, C. Bermudez¹, M. Crespo¹, J. Diamond¹
¹University of Pennsylvania, Philadelphia, PA, ²University of Miami, Miami, FL
*Purpose: The advent of direct acting antiviral therapy has motivated centers to transplant lungs from donors with hepatitis C virus infection (HCV-RNA+) into uninfected recipients.…
2022 American Transplant Congress
Mortality in Solid Organ Transplant Recipients with a Pretransplant Cancer Diagnosis
A. Hart¹, R. Pfeiffer², B. Morawski³, C. Lynch⁴, Y. Zeng⁵, K. Pawlish⁶, K. Yu⁷, D. Hurley⁸, E. Engels⁷
¹Hennepin Healthcare, University of Minnesota, Minneapolis, MN, ²Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, ³Cancer Registry of Idaho, Boise, ID, ⁴Epidemiology, University of Iowa, Iowa City, IA, ⁵North Dakota Statewide Cancer Registry, Grand Forks, ND, ⁶New Jersey State Cancer Registry, Trenton, NJ, ⁷Infections and Immunoepidemiology Branch, National Cancer Institute, Bethesda, MD, ⁸University of South Carolina, Columbia, SC
*Purpose: Transplant-associated immunosuppression may cause cancer recurrence in patients with a pretransplant cancer, but little is known about outcomes among these recipients.*Methods: We used data…